Form 4: InfuSystem Holdings Director Scott Shuda Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Director Scott Shuda reports acquisition of stock options and beneficial ownership of InfuSystem Holdings, Inc. shares.

Summary

  • Scott Shuda, a director of InfuSystem Holdings, Inc., filed a Form 4 detailing changes in his beneficial ownership.
  • The report indicates that Shuda directly owns 101,994 shares of common stock.
  • He also indirectly owns 298,383 shares.
  • Shuda was granted options to purchase 39,588 shares and 11,876 shares of InfuSystem Holdings, Inc. common stock at an exercise price of $6.
  • These options vest on May 16, 2026, and expire on May 16, 2035.
  • Shuda serves as Managing Director of TSV Investment Partners, LLC and BlueLine Partners, LLC, which are the sole general partners of Meridian OHC Partners, LP and BlueLine Capital Partners II, respectively.
  • He holds voting and dispositive power over the Common Stock held by Meridian and BlueLine but disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, so the sentiment is considered neutral.

Positives

  • The acquisition of stock options aligns Shuda's interests with those of the shareholders, incentivizing him to work towards increasing the company's value.

Future Outlook

There is no specific future outlook provided in this document.

Industry Context

This filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and are comparable across industries.
  • The size and terms of the stock options granted to Scott Shuda can be compared to similar grants made to directors at comparable companies in the healthcare technology sector.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding the holdings of a company director.
  • The stock option grant aligns the director's interests with those of the shareholders.

Key Dates

DateDescription
05/16/2025Date of earliest transaction reported.
05/16/2026Vesting date for the stock options.
05/16/2035Expiration date for the stock options.
05/20/2025Date of signature on the Form 4 filing.

Keywords

Form 4, beneficial ownership, stock options, InfuSystem Holdings, Scott Shuda, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.